Robert W. Baird set a $97.00 target price on Davita (NYSE:DVA) in a report issued on Tuesday morning. The firm currently has a buy rating on the stock.

DVA has been the subject of several other research reports. Raymond James Financial upgraded shares of Davita from an outperform rating to a strong-buy rating and raised their price target for the stock from $65.00 to $84.00 in a report on Thursday, December 7th. Bank of America upgraded shares of Davita from a neutral rating to a buy rating and raised their price target for the stock from $75.00 to $85.00 in a report on Thursday, January 4th. Royal Bank of Canada lowered their price target on shares of Davita from $64.00 to $60.00 and set a sector perform rating for the company in a report on Wednesday, November 8th. KeyCorp restated a hold rating on shares of Davita in a report on Monday, November 13th. Finally, SunTrust Banks set a $75.00 price target on shares of Davita and gave the stock a hold rating in a report on Thursday, December 21st. Two analysts have rated the stock with a sell rating, five have given a hold rating, four have assigned a buy rating and two have assigned a strong buy rating to the company. The stock presently has an average rating of Hold and a consensus price target of $78.80.

Davita (NYSE:DVA) traded down $0.37 during trading on Tuesday, reaching $73.17. 1,281,814 shares of the company’s stock traded hands, compared to its average volume of 1,399,521. The company has a current ratio of 1.40, a quick ratio of 1.35 and a debt-to-equity ratio of 1.79. Davita has a 52-week low of $52.51 and a 52-week high of $80.71. The company has a market cap of $13,456.05, a price-to-earnings ratio of 28.20 and a beta of 0.99.

Davita (NYSE:DVA) last released its quarterly earnings results on Tuesday, February 13th. The company reported $0.92 earnings per share (EPS) for the quarter, missing the consensus estimate of $0.94 by ($0.02). Davita had a return on equity of 13.31% and a net margin of 3.40%. The firm had revenue of $2.78 billion for the quarter, compared to the consensus estimate of $3.90 billion. During the same quarter in the previous year, the business posted $0.98 EPS. equities research analysts expect that Davita will post 3.44 EPS for the current fiscal year.

In other news, VP Leanne M. Zumwalt sold 949 shares of the firm’s stock in a transaction that occurred on Friday, December 8th. The shares were sold at an average price of $68.19, for a total transaction of $64,712.31. Following the completion of the sale, the vice president now owns 12,423 shares of the company’s stock, valued at approximately $847,124.37. The sale was disclosed in a legal filing with the SEC, which is accessible through this link. Also, insider James K. Hilger sold 5,608 shares of the firm’s stock in a transaction that occurred on Thursday, December 7th. The stock was sold at an average price of $69.46, for a total transaction of $389,531.68. Following the sale, the insider now directly owns 47,649 shares of the company’s stock, valued at approximately $3,309,699.54. The disclosure for this sale can be found here. In the last ninety days, insiders have sold 121,509 shares of company stock valued at $8,310,388. Insiders own 2.00% of the company’s stock.

Hedge funds have recently made changes to their positions in the company. Coastline Trust Co grew its position in Davita by 6.3% in the 4th quarter. Coastline Trust Co now owns 16,120 shares of the company’s stock valued at $1,165,000 after purchasing an additional 950 shares during the period. Public Employees Retirement Association of Colorado grew its position in Davita by 3.5% in the 4th quarter. Public Employees Retirement Association of Colorado now owns 29,076 shares of the company’s stock valued at $2,101,000 after purchasing an additional 974 shares during the period. Creative Planning grew its position in Davita by 8.6% in the 4th quarter. Creative Planning now owns 13,137 shares of the company’s stock valued at $949,000 after purchasing an additional 1,044 shares during the period. Crossmark Global Holdings Inc. grew its position in Davita by 7.0% in the 4th quarter. Crossmark Global Holdings Inc. now owns 25,163 shares of the company’s stock valued at $1,818,000 after purchasing an additional 1,650 shares during the period. Finally, Amalgamated Bank grew its position in Davita by 9.7% in the 4th quarter. Amalgamated Bank now owns 19,246 shares of the company’s stock valued at $1,391,000 after purchasing an additional 1,698 shares during the period. 84.45% of the stock is owned by institutional investors.

TRADEMARK VIOLATION WARNING: This story was first reported by TheOlympiaReport and is owned by of TheOlympiaReport. If you are accessing this story on another publication, it was illegally stolen and reposted in violation of US & international trademark & copyright laws. The legal version of this story can be viewed at https://theolympiareport.com/2018/02/14/davita-dva-pt-set-at-97-00-by-robert-w-baird.html.

Davita Company Profile

DaVita Inc, formerly DaVita HealthCare Partners Inc, operates two divisions: DaVita Kidney Care (Kidney Care) and DaVita Medical Group (DMG). The Kidney Care division consists of its the United States dialysis and related lab services, its ancillary services and strategic initiatives, including its international operations, and its corporate administrative support.

Analyst Recommendations for Davita (NYSE:DVA)

Receive News & Ratings for Davita Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Davita and related companies with MarketBeat.com's FREE daily email newsletter.